The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel
2013
AbstractObjective: Gestational diabetes mellitus (GDM) is associated with elevated risks of perinatal complications and type 2 diabetes mellitus, and screening and intervention can reduce these risks. We quantified the cost, health impact and cost-effectiveness of GDM screening and intervention in India and Israel, settings with contrasting epidemiologic and cost environments.Methods: We developed a decision-analysis tool (the GeDiForCE™) to assess cost-effectiveness. Using both local data and published estimates, we applied the model for a general medical facility in Chennai, India and for the largest HMO in Israel. We computed costs (discounted international dollars), averted disability-adjusted life years (DALYs) and net cost per DALY averted, compared with no GDM screening.Results: The programme costs per 1000 pregnant women are $259 139 in India and $259 929 in Israel. Net costs, adjusted for averted disease, are $194 358 and $76 102, respectively. The cost per DALY averted is $1626 in India and $183...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
46
References
49
Citations
NaN
KQI